deltatrials
Recruiting PHASE4 INTERVENTIONAL 2-arm NCT03968393

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress (ASPIRE-AF)

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress - The ASPIRE-AF Trial

Sponsor: Hamilton Health Sciences Corporation

Conditions Atrial Fibrillation Stroke
Interventions Non-vitamin K oral anticoagulant (NOAC)
Updated 17 times since 2019 Last updated: Jan 8, 2026 Started: Jun 14, 2019 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03968393, this PHASE4 trial focuses on Atrial Fibrillation and Stroke and remains actively recruiting participants. Sponsored by Hamilton Health Sciences Corporation, it has been updated 17 times since 2019, reflecting substantial change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

~Jun 2019 – ~Aug 2019 · 2 months · monthly snapshot~Aug 2019 – ~Nov 2020 · 15 months · monthly snapshot~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshot~Jan 2021 – ~Sep 2021 · 8 months · monthly snapshot~Sep 2021 – ~Apr 2022 · 7 months · monthly snapshot~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshot~Sep 2022 – ~Nov 2022 · 2 months · monthly snapshot~Nov 2022 – ~Aug 2023 · 9 months · monthly snapshot~Aug 2023 – ~Nov 2023 · 3 months · monthly snapshot~Nov 2023 – ~Apr 2024 · 5 months · monthly snapshot~Apr 2024 – ~Jul 2024 · 3 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jun 2025 · 9 months · monthly snapshot~Jun 2025 – ~Jul 2025 · 30 days · monthly snapshot~Jul 2025 – ~Sep 2025 · 2 months · monthly snapshot~Sep 2025 – ~Feb 2026 · 5 months · monthly snapshot~Feb 2026 – present · 4 months · monthly snapshot

Change History

17 versions recorded

  1. Feb 2026 — Present [monthly]

    Recruiting PHASE4

  2. Sep 2025 — Feb 2026 [monthly]

    Recruiting PHASE4

  3. Jul 2025 — Sep 2025 [monthly]

    Recruiting PHASE4

  4. Jun 2025 — Jul 2025 [monthly]

    Recruiting PHASE4

  5. Sep 2024 — Jun 2025 [monthly]

    Recruiting PHASE4

▶ Show 12 earlier versions

  1. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE4

  2. Apr 2024 — Jul 2024 [monthly]

    Recruiting PHASE4

  3. Nov 2023 — Apr 2024 [monthly]

    Recruiting PHASE4

  4. Aug 2023 — Nov 2023 [monthly]

    Recruiting PHASE4

  5. Nov 2022 — Aug 2023 [monthly]

    Recruiting PHASE4

  6. Sep 2022 — Nov 2022 [monthly]

    Recruiting PHASE4

  7. Apr 2022 — Sep 2022 [monthly]

    Recruiting PHASE4

    Phase: PHASE3 → PHASE4

  8. Sep 2021 — Apr 2022 [monthly]

    Recruiting PHASE3

  9. Jan 2021 — Sep 2021 [monthly]

    Recruiting PHASE3

  10. Nov 2020 — Jan 2021 [monthly]

    Recruiting PHASE3

  11. Aug 2019 — Nov 2020 [monthly]

    Recruiting PHASE3

    Status: Not Yet Recruiting → Recruiting

  12. Jun 2019 — Aug 2019 [monthly]

    Not Yet Recruiting PHASE3

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Hamilton Health Sciences Corporation
  • Population Health Research Institute
Data source: Population Health Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

's-Hertogenbosch, Netherlands , Aarhus, Denmark , Adelaide, Australia , Ahmedabad, India , Alappuzha, India , Alessandria, Italy , Alkmaar, Netherlands , Almelo, Netherlands , Amstelveen, Netherlands , Arnhem, Netherlands and 80 more locations